Cargando…

Frequency-dependent exacerbation of Alzheimer’s disease neuropathophysiology

Neuronal activity patterns are disrupted in neurodegenerative disorders, including Alzheimer’s disease (AD). One example is disruption of corticothalamic slow oscillations responsible for sleep-dependent memory consolidation. Slow waves are periodic oscillations in neuronal activity occurring at fre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kastanenka, Ksenia V., Calvo-Rodriguez, Maria, Hou, Steven S., Zhou, Heng, Takeda, Shuko, Arbel-Ornath, Michal, Lariviere, Amanda, Lee, Yee Fun, Kim, Alex, Hawkes, Jonathan M., Logan, Robert, Feng, Danielle, Chen, Xiqun, Gomperts, Stephen N., Bacskai, Brian J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586873/ https://www.ncbi.nlm.nih.gov/pubmed/31221985 http://dx.doi.org/10.1038/s41598-019-44964-z

Ejemplares similares

Novel Botanical Therapeutic NB-02 Effectively Treats Alzheimer’s Neuropathophysiology in an APP/PS1 Mouse Model
por: Lee, Yee Fun, et al.
Publicado: (2021)

An acute functional screen identifies an effective antibody targeting amyloid-β oligomers based on calcium imaging
por: Wang, Xueying, et al.
Publicado: (2018)

Optogenetic Restoration of Disrupted Slow Oscillations Halts Amyloid Deposition and Restores Calcium Homeostasis in an Animal Model of Alzheimer’s Disease
por: Kastanenka, Ksenia V., et al.
Publicado: (2017)

Slow Wave Sleep Is a Promising Intervention Target for Alzheimer’s Disease
por: Lee, Yee Fun, et al.
Publicado: (2020)

Low frequency visual stimulation enhances slow wave activity without disrupting the sleep pattern in mice
por: Thankachan, Stephen, et al.
Publicado: (2022)

Optogenetic Targeting of Astrocytes Restores Slow Brain Rhythm Function and Slows Alzheimer’s Disease Pathology
por: Lee, Yee Fun, et al.
Publicado: (2023)

Sleep restoration by optogenetic targeting of GABAergic neurons reprograms microglia and ameliorates pathological phenotypes in an Alzheimer’s disease model
por: Zhao, Qiuchen, et al.
Publicado: (2023)

Dystrophin Dp71 and the Neuropathophysiology of Duchenne Muscular Dystrophy
por: Naidoo, Michael, et al.
Publicado: (2019)

Neuropathophysiological Mechanisms and Treatment Strategies for Post-traumatic Epilepsy
por: Sharma, Shaunik, et al.
Publicado: (2021)

Overview of the Role of Vanillin in Neurodegenerative Diseases and Neuropathophysiological Conditions
por: Iannuzzi, Clara, et al.
Publicado: (2023)

Optogenetic targeting of astrocytes restores slow brain rhythm function and slows Alzheimer’s disease pathology
por: Lee, Yee Fun, et al.
Publicado: (2023)

Review of salicylate-induced hearing loss, neurotoxicity, tinnitus and neuropathophysiology
por: SHEPPARD, A., et al.
Publicado: (2014)

Soluble oligomeric amyloid-β induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain
por: Arbel-Ornath, Michal, et al.
Publicado: (2017)

Optimization of real-time analysis of sleep-wake cycle in mice
por: Thankachan, Stephen, et al.
Publicado: (2022)

Lymphatic Clearance of the Brain: Perivascular, Paravascular and Significance for Neurodegenerative Diseases
por: Bakker, Erik N. T. P., et al.
Publicado: (2016)

Neurotrophins in the Neuropathophysiology, Course, and Complications of Obstructive Sleep Apnea—A Narrative Review
por: Gabryelska, Agata, et al.
Publicado: (2023)

Novel botanical drug DA-9803 prevents deficits in Alzheimer’s mouse models
por: Pagnier, Guillaume J., et al.
Publicado: (2018)

Traumatic Brain Injury Severity, Neuropathophysiology, and Clinical Outcome: Insights from Multimodal Neuroimaging
por: Irimia, Andrei, et al.
Publicado: (2017)

Neuropathophysiology, Genetic Profile, and Clinical Manifestation of Mucolipidosis IV—A Review and Case Series
por: Jezela-Stanek, Aleksandra, et al.
Publicado: (2020)

Neuropathophysiology of Lysosomal Storage Diseases: Synaptic Dysfunction as a Starting Point for Disease Progression
por: Pará, Camila, et al.
Publicado: (2020)

Nuclear Factor Erythroid-2-Related Factor 2 Signaling in the Neuropathophysiology of Inherited Metabolic Disorders
por: Seminotti, Bianca, et al.
Publicado: (2021)

Insights into the Promising Prospect of G Protein and GPCR-Mediated Signaling in Neuropathophysiology and Its Therapeutic Regulation
por: Rahman, Md. Mominur, et al.
Publicado: (2022)

Bioenergetics and neuroimaging research: a neuropathophysiological linkage in the setting of cocaine use amongst persons with HIV
por: White, Cory J., et al.
Publicado: (2023)

Reduced excitatory neuron activity and interneuron-type-specific deficits in a mouse model of Alzheimer’s disease
por: Algamal, Moustafa, et al.
Publicado: (2022)

Multimodal MRI of myalgic encephalomyelitis/chronic fatigue syndrome: A cross-sectional neuroimaging study toward its neuropathophysiology and diagnosis
por: Shan, Zack Y., et al.
Publicado: (2022)

Label-free imaging of amyloid plaques in Alzheimer’s disease with stimulated Raman scattering microscopy
por: Ji, Minbiao, et al.
Publicado: (2018)

High mitochondrial calcium levels precede neuronal death in vivo in Alzheimer's disease
por: Calvo-Rodriguez, Maria, et al.
Publicado: (2020)

Pathogenic PS1 phosphorylation at Ser367
por: Maesako, Masato, et al.
Publicado: (2017)

CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer’s Disease
por: György, Bence, et al.
Publicado: (2018)

Building transformers from neurons and astrocytes
por: Kozachkov, Leo, et al.
Publicado: (2023)

Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection
por: Welcome, Menizibeya O., et al.
Publicado: (2021)

Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer’s Disease
por: Calvo-Rodriguez, Maria, et al.
Publicado: (2020)

Exacerbation frequency and course of COPD
por: Halpin, David MG, et al.
Publicado: (2012)

Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy
por: Takeda, Shuko, et al.
Publicado: (2014)

Factors associated with change in exacerbation frequency in COPD
por: Donaldson, Gavin C, et al.
Publicado: (2013)

Frequency of Exacerbations in COPD: An Analysis of the SPIROMICS Cohort
por: Han, MeiLan K., et al.
Publicado: (2017)

Tau Propagation as a Diagnostic and Therapeutic Target for Dementia: Potentials and Unanswered Questions
por: Takeda, Shuko
Publicado: (2019)

Chronic obstructive pulmonary disease exacerbation frequency and severity
por: Stafyla, Eirini, et al.
Publicado: (2013)

Clinical Features according to the Frequency of Acute Exacerbation in COPD
por: Lee, Seung Jun, et al.
Publicado: (2012)

Predictors of exacerbation frequency in chronic obstructive pulmonary disease
por: Yang, Hui, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2cmelqr0uevttl6fj0cj1b1702